Bonnett, L.

The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification

Wynn, G. J., Todd, D. M., Webber, M., Bonnett, L., McShane, J., Kirchhof, P., & Gupta, D. (2014) · Europace

Atrial Fibrillation Management and OutcomesCardiac Health and Mental Health

Cited by 254

Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study

McGill, F., Griffiths, M. J., Bonnett, L. J., Geretti, A. M., Michael, B. D., Beeching, N. J., McKee, D., Scarlett, P., Hart, I. J., Mutton, K. J., et al. (2018) · The Lancet Infectious Diseases

Infectious Encephalopathies and EncephalitisBacterial Infections and Vaccines

Cited by 193

Child development following in utero exposure: Levetiracetam vs sodium valproate

Shallcross, R., Bromley, R. L., Irwin, B., Bonnett, L. J., Morrow, J., & Baker, G. A. (2011) · Neurology

Pharmacological Effects and Toxicity StudiesEpilepsy research and treatment

Cited by 161

Efficacy of Catheter Ablation for Persistent Atrial Fibrillation: A Systematic Review and Meta-Analysis of Evidence From Randomized and Nonrandomized Controlled Trials

Wynn, G. J., Das, M., Bonnett, L. J., Panikker, S., Wong, T., & Gupta, D. (2014) · Circulation Arrhythmia and Electrophysiology

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 146

Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial

Bonnett, L., Smith, C. T., Smith, D., Williamson, P., Chadwick, D., & Marson, A. G. (2012) · The Lancet Neurology

Epilepsy research and treatmentPharmacological Effects and Toxicity Studies

Cited by 69